Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

2 days ago · Tempus is in the process of completing its customary year-end close and review procedures for the quarter and year ended December 31, 2025, and there can be no …

23 hours ago · Tempus plans to report its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. About Tempus Tempus is a technology …

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public …

20 hours ago · Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.

Dec 15, 2025 · Get Tempus AI Inc (TEM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

16 hours ago · Tempus AI TEM stock has delivered a remarkable 105% gain over the past year, driven by strong performance across both its Genomics and Data segments, surpassing initial …

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for …

15 hours ago · Complete Tempus AI Inc. stock information by Barron's. View real-time TEM stock price and news, along with industry-best analysis.

Jan 6, 2026 · Tempus is a public company based in Chicago (United States), founded in 2015 by Eric Lefkofsky. It operates as an AI-based precision medicine solutions for oncology. Tempus …